Inclusion of women, minorities, and children in clinical trials: Opinions of research ethics board administrators

Journal of Empirical Research on Human Research Ethics

Volumn 4, Issue 2, 2009, Pages 65-73

  Taylor, Holly A ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Inclusion policy; Justice; National Institutes of Health; Research Ethics Board administrators

Indexed keywords

AGE; ARTICLE; ATTITUDE; CHILD; ETHICS; FEMALE; HUMAN; MALE; MINORITY GROUP; PATIENT SELECTION; PRACTICE GUIDELINE; PROFESSIONAL STANDARD; SEX DIFFERENCE; UNITED STATES;

AGE FACTORS; ATTITUDE; CHILD; ETHICS COMMITTEES, RESEARCH; FEMALE; GUIDELINES AS TOPIC; HUMANS; MALE; MINORITY GROUPS; PATIENT SELECTION; SEX FACTORS; UNITED STATES; WOMEN;

EID: 68849091033     PISSN: 15562646     EISSN: 15562654     Source Type: Journal    
DOI: 10.1525/jer.2009.4.2.65     Document Type: Article

References (40)

1. BHOPAL, R. (2006). Race and ethnicity: Responsible use from epidemiological and public health perspectives. The Journal of Law, Medicine & Ethics, 34, 500-507.
2. BLOCHE, M. G. (2006). Race, money, and medicines. The Journal of Law, Medicine & Ethics, 34, 555-558.
3. BRAWLEY, O. W. (1995). Response to "Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993-The perspective of NIH clinical trialists." Controlled Clinical Trials, 16(5), 293-295.
4. BREWER, R. M. (2006). Thinking critically about race and genetics. The Journal of Law, Medicine & Ethics, 34, 513-519.
5. BUIST, A. S. & GREENLICK, M. R. (1995). Response to "Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993-The perspective of NIH clinical trialists." Controlled Clinical Trials, 16(5), 296-298.
6. CHO, M. K. (2006). Racial and ethnic categories in biomedical research: There is no baby in the bathwater. The Journal of Law, Medicine & Ethics, 34, 497-499.
7. COHN, J. N. (2006). The use of race and ethnicity in medicine: Lessons from the African-American heart failure trial. The Journal of Law, Medicine & Ethics, 34, 552-554.
8. Committee on the Ethical and Legal Issues Relating to the Inclusion of Women in Clinical Studies, Institute of Medicine.(1994). Women and Health Research, Volume 1: Ethical and Legal Issues of Including Women in Clinical Studies. A. C. Mastroianni, R. Faden, and D. Federman, Eds. Washington, D.C.: National Academy Press.
9. CORBIE-SMITH, G. M., DURANT, R. W., & ST. GEORGE, D. M. M. (2006). Investigators'assessment of NIH mandated inclusion of women and minorities in research. Contemporary Clinical Trials, 27(6), 571-579.
10. CORBIE-SMITH, G. M., MILLER, W. C., & RANSOHOFF, D. F. (2004). Interpretations of'appropriate'minority inclusion in clinical research. American Journal of Medicine, 116(4), 249-252.
11. DEVRIES, R. G. & FORSBERG, C. P. (2002). What do IRBs look like? What kind of support do they receive? Accountability in Research, 9(3/4), 199-216.
12. DILLMAN, D. A. (2000). Mail and Internet surveys: The tailored design method, 1st ed. New York: John Wiley & Sons.
13. DUSTER, T. (2006). Lessons from history: why race and ethnicity have played a major role in biomedical research. The Journal of Law, Medicine & Ethics, 34, 487-496.
14. ERNST, A. A., WEISS, S. J., NICK, T. G., ISERSON, K., & BIROS, M. H. (2005). Minimal-risk waiver of informed consent and exception from informed consent (final rule) studies at institutional review boards nationwide. Academic Emergency Medicine, 12(11), 1134-1137.
15. FOSTER, M. (2006). Analyzing the use of race and ethnicity in biomedical research from a local community perspective. The Journal of Law, Medicine & Ethics, 34, 508-512.
16. FREEDMAN, L. S., SIMON, R., FOULKES, M. A., FRIEDMAN, L., GELLER, N. L., GORDON, D. J., MOWERY, R. (1995). Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993-The perspective of NIH clinical trialists. Controlled Clinical Trials, 16(5), 277-285.
17. JONES, J. S., WHITE, L. J., POOL, L. C., & DOUGHERTY, J. M. (1996). Structure and practice of institutional review boards in the United States. Academic Emergency Medicine, 3(8), 804-809.
18. KODISH, E., STOCKING, C., RATAIN, M. J., KOHRMAN, A., & SIEGLER, M. (1992). Ethical issues in phase I oncology research: A comparison of investigators and institutional review board chairpersons. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 10(11), 1810-1816.
19. LEVINE, C. (1996). Changing Views of Justice after Belmont: AIDS and Inclusion of'Vulnerable'Subjects. The Ethics of Research Involving Human Subjects: Facing the 21st Century. H.Y. Vanderpool editor. Frederick, MD: UPG.
20. MARSHALL, E. (2005). Clinical trials: keeping score on the sexes. Science 308, 1571.
21. MASTROIANNI, A., & KAHN, J. (2001). Swinging on the pendulum: shifting views of justice in human subjects research. Hastings Center Report, 31, 21-28.
22. MEINERT, C. L. (1995). Comments on NIH clinical trials valid analysis requirement. Controlled Clinical Trials, 16(5), 304-306.
23. MEINERT, C. L., GILPIN, A. K., ÜNALP, A., & DAWSON, C. (2000). Gender representation in trials. Controlled Clinical Trials, 21(5), 462-475.
24. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. (1979). The Belmont report: Ethical principles and guidelines for the protection of human subjects of research. Available online at http://www. hhs.gov/ohrp/humansubjects/guidance/belmont.htm.
25. National Institutes of Health. (1994). NIH guidelines for the inclusion of women and minorities as subjects in clinical research. Retrieved March 11, 2009 from http://grants.nih. gov/grants/guide/notice-files/not94-100.html.
26. National Institutes of Health. (1997). Outreach notebook for the NIH guidelines on inclusion of women and minorities as subjects in clinical research. NIH Publication No. 97-4160.
27. National Institutes of Health. (1998). NIH policy and guidelines on the inclusion of children as participants in research involving human subjects. Retrieved February 16, 2009 from http://grants.nih.gov/grants/guide/notice- files/not98-024.html.
28. National Institutes of Health. (2001). Amendment: NIH policy and guidelines on the inclusion of women and minorities as subjects in clinical research. Retrieved February 16, 2009 from http://grants.nih.gov/grants/guide/ notice-files/NOTOD-02-001.html.
29. PIANTADOSI. S. (1995). Commentary regarding "Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993-The perspective of NIH clinical trialists." Controlled Clinical Trials, 16(5), 307-309.
30. Public Law 103-143 (1993). National Institutes of Health Revitalization Act of 1993: Plan for Use of Animals in Research. Available online at http://grants.nih.gov/grants/olaw/pl103-43.pdf.
31. RATHORE, S. S. & KRUMHOLZ, H. M. (2003). Race, ethnic group and clinical research. British Medical Journal, 327(7418), 763-764.
32. StataCorp LP (2001). STATA. College Station, TX.
33. TAYLOR, H. A. (2008). Implementation of NIH inclusion guidelines: Survey of NIH study section members. Clinical Trials, 5(2), 140-146.
34. U.S. General Accounting Office. (1990). National institutes of health: problems in implementing policy on women in study populations. Statement of Mark V. Nadel before the Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives. GAO/T-HRD-90-138 Available online at http://archive.gao.gov/d48t13/141601.pdf.
35. VASTAG, B. (2003). Researchers say changes needed in recruitment policies for NIH trials. Journal of the American Medical Association, 289(5), 536-537.
36. WEISE, K. L., SMITH, M. L., MASCHKE, K. J., & COPELAND, H. L. (2002). National practices regarding payment to research subjects for participating in pediatric research. Pediatrics, 110(3), 577-582.
37. WHITE, M. T. & GAMM, J. (2002). Informed consent for research on stored blood and tissue samples: A survey of institutional review board practices. Accountability in Research, 9(1), 1-16.
38. WHITTLE, A., SHAH, S., WILFOND, B., GENSLER, G., & WENDLER, D. (2004). Institutional review board practices regarding assent in pediatric research. Pediatrics, 113(6), 1747-1752.
39. WOLF, S. M. (2006). Debating the use of racial and ethnic categories in research. The Journal of Law, Medicine & Ethics, 34, 483-486.
40. WOOLSON, R. F., JONES, M. F., CLARKE, W. R., & TORNER, J. C. (1995). Discussion of "Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993-The perspective of NIH clinical trialists." Controlled Clinical Trials, 16(5), 301-303.